• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞因子诱导的杀伤细胞是II型自然杀伤T细胞。

Cytokine-induced killer cells are type II natural killer T cells.

作者信息

Gütgemann Stefan, Frank Susanne, Strehl John, Schmidt-Wolf Ingo G H

机构信息

Department of Internal Medicine I, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany.

出版信息

Ger Med Sci. 2007 Sep 10;5:Doc07.

PMID:19675715
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2703238/
Abstract

BACKGROUND

Until now, cytokine-induced killer (CIK) cells were assumed to be part of the type I natural killer T (NKT) cell population, but it was not yet investigated if this is correct.

METHODS

For analysis, CIK cells were generated by various culture conditions. Human type I NKT cells express a T cell receptor (TCR) composed of an invariant V alpha 24-J alpha Q chain combined with one of several V beta chains. The V alpha 24 is a reliable marker for the presence of these TCRs.

RESULTS

While comparing cultures stimulated with different substances, we observed the lack of any V alpha 24 on the surface of CIK culture cells.

CONCLUSION

We conclude that CIK cells do not belong to the type I NKT cells.

摘要

背景

到目前为止,细胞因子诱导的杀伤(CIK)细胞被认为是I型自然杀伤T(NKT)细胞群体的一部分,但这一观点是否正确尚未得到研究。

方法

为了进行分析,通过各种培养条件生成CIK细胞。人类I型NKT细胞表达一种由不变的Vα24-JαQ链与几种Vβ链之一组合而成的T细胞受体(TCR)。Vα24是这些TCR存在的可靠标志物。

结果

在比较用不同物质刺激的培养物时,我们观察到CIK培养细胞表面缺乏任何Vα24。

结论

我们得出结论,CIK细胞不属于I型NKT细胞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c70/2703238/3313f0f446dd/GMS-05-07-g-001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c70/2703238/a867d6503a47/GMS-05-07-t-001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c70/2703238/3313f0f446dd/GMS-05-07-g-001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c70/2703238/a867d6503a47/GMS-05-07-t-001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c70/2703238/3313f0f446dd/GMS-05-07-g-001.jpg

相似文献

1
Cytokine-induced killer cells are type II natural killer T cells.细胞因子诱导的杀伤细胞是II型自然杀伤T细胞。
Ger Med Sci. 2007 Sep 10;5:Doc07.
2
Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.(树突状细胞刺激的)恒定自然杀伤T细胞、自然杀伤细胞和细胞因子诱导的杀伤细胞的频率、组成和/或抗白血病活性对急性髓系白血病、急性淋巴细胞白血病和慢性淋巴细胞白血病患者预后的意义。
J Immunother. 2017 Jul/Aug;40(6):224-248. doi: 10.1097/CJI.0000000000000171.
3
Dendritic cells are targets for human invariant Valpha24+ natural killer T-cell cytotoxic activity: an important immune regulatory function.树突状细胞是人类恒定链α24 +自然杀伤T细胞细胞毒性活性的靶标:一种重要的免疫调节功能。
Exp Hematol. 2000 Mar;28(3):276-82. doi: 10.1016/s0301-472x(99)00149-6.
4
Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells.由α-半乳糖神经酰胺(KRN7000)激活的人类恒定Vα24 +自然杀伤T细胞通过不同于T细胞和自然杀伤细胞的机制具有细胞毒性抗肿瘤活性。
Immunology. 2000 Feb;99(2):229-34. doi: 10.1046/j.1365-2567.2000.00952.x.
5
Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.人类恒定Vα24-JαQ TCR支持转基因小鼠中CD1d依赖性NK1.1 +和NK1.1-T细胞的发育。
J Immunol. 2003 Mar 1;170(5):2390-8. doi: 10.4049/jimmunol.170.5.2390.
6
Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.使用自然杀伤细胞相关标志物定义新型 CD1d 依赖性 II 型自然杀伤 T 细胞亚群。
Scand J Immunol. 2019 Sep;90(3):e12794. doi: 10.1111/sji.12794. Epub 2019 Jun 26.
7
Frequency of Valpha24+CD161+ natural killer T cells and invariant TCRAV24-AJ18 transcripts in atopic and non-atopic individuals.特应性和非特应性个体中Vα24⁺CD161⁺自然杀伤T细胞的频率及恒定链TCRαV24-AJ18转录本
Immunobiology. 2003;208(4):367-80. doi: 10.1078/0171-2985-00284.
8
Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes.人CD4(+)和CD8αβ(+) T淋巴细胞对α-半乳糖神经酰胺的Valpha24-JalphaQ非依赖性、CD1d限制性识别。
J Immunol. 2002 Jun 1;168(11):5514-20. doi: 10.4049/jimmunol.168.11.5514.
9
Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors.Vβ8.2和Vβ7半不变自然杀伤T细胞受体对CD1d-α-半乳糖神经酰胺的差异识别
Immunity. 2009 Jul 17;31(1):47-59. doi: 10.1016/j.immuni.2009.04.018.
10
The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.细胞因子诱导的杀伤细胞的双重功能特性及其在肿瘤免疫学中的应用。
Hum Immunol. 2015 May;76(5):385-91. doi: 10.1016/j.humimm.2014.09.021. Epub 2014 Oct 8.

引用本文的文献

1
CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma.嵌合抗原受体细胞因子诱导的杀伤细胞(CAR-CIK)与嵌合抗原受体T细胞(CAR-T)对比:将新型细胞因子诱导的杀伤细胞作为erbB2阳性横纹肌肉瘤实体瘤免疫疗法的基准研究
Front Immunol. 2025 Feb 3;16:1485817. doi: 10.3389/fimmu.2025.1485817. eCollection 2025.
2
CAR products from novel sources: a new avenue for the breakthrough in cancer immunotherapy.新型来源的 CAR 产品:癌症免疫治疗突破的新途径。
Front Immunol. 2024 Apr 11;15:1378739. doi: 10.3389/fimmu.2024.1378739. eCollection 2024.
3
tumor vaccination by percutaneous ablative therapy and its synergy with immunotherapeutics: An update on combination therapy.

本文引用的文献

1
Synergistic antitumor effects of immune cell-viral biotherapy.免疫细胞-病毒生物疗法的协同抗肿瘤作用。
Science. 2006 Mar 24;311(5768):1780-4. doi: 10.1126/science.1121411.
2
Expansion of Valpha24(+)Vbeta11(+) NKT cells from cord blood mononuclear cells using IL-15, IL-7 and Flt3-L depends on monocytes.使用白细胞介素-15、白细胞介素-7和Flt3配体从脐血单个核细胞中扩增Valpha24(+)Vbeta11(+)自然杀伤T细胞依赖于单核细胞。
Eur J Immunol. 2006 Jan;36(1):236-44. doi: 10.1002/eji.200526085.
3
Functionally distinct NKT cell subsets and subtypes.功能不同的NKT细胞亚群和亚型。
经皮消融治疗的肿瘤疫苗接种及其与免疫治疗的协同作用:联合治疗的最新进展。
Front Immunol. 2023 Mar 8;14:1118845. doi: 10.3389/fimmu.2023.1118845. eCollection 2023.
4
Anti-CD40 predominates over anti-CTLA-4 to provide enhanced antitumor response of DC-CIK cells in renal cell carcinoma.抗 CD40 优于抗 CTLA-4,可增强 DC-CIK 细胞对肾细胞癌的抗肿瘤反应。
Front Immunol. 2022 Aug 25;13:925633. doi: 10.3389/fimmu.2022.925633. eCollection 2022.
5
Recent Development in NKT-Based Immunotherapy of Glioblastoma: From Bench to Bedside.基于自然杀伤 T 细胞的胶质母细胞瘤免疫治疗的最新进展:从基础到临床。
Int J Mol Sci. 2022 Jan 24;23(3):1311. doi: 10.3390/ijms23031311.
6
Cell therapies in the clinic.临床中的细胞疗法。
Bioeng Transl Med. 2021 Feb 26;6(2):e10214. doi: 10.1002/btm2.10214. eCollection 2021 May.
7
One Single Site Clinical Study: To Evaluate the Safety and Efficacy of Immunotherapy With Autologous Dendritic Cells, Cytokine-Induced Killer Cells in Primary Hepatocellular Carcinoma Patients.一项单中心临床研究:评估自体树突状细胞联合细胞因子诱导的杀伤细胞免疫疗法在原发性肝癌患者中的安全性和有效性。
Front Oncol. 2020 Nov 25;10:581270. doi: 10.3389/fonc.2020.581270. eCollection 2020.
8
Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer.细胞因子诱导的杀伤细胞作为联合免疫疗法增强对肾癌的疗效。
Int J Mol Sci. 2020 Apr 27;21(9):3078. doi: 10.3390/ijms21093078.
9
Radiotherapy combined with cytokine-induced killer cell therapy for liver metastasis from rectal cancer: A case report.放疗联合细胞因子诱导的杀伤细胞疗法治疗直肠癌肝转移:一例报告
Medicine (Baltimore). 2019 Oct;98(43):e17636. doi: 10.1097/MD.0000000000017636.
10
Clinical benefits of Livin peptide-loaded DCs/CIKs combined with chemotherapy in advanced non-small cell lung cancer.负载Livin肽的树突状细胞/细胞因子诱导的杀伤细胞联合化疗在晚期非小细胞肺癌中的临床益处
Am J Cancer Res. 2019 Feb 1;9(2):406-414. eCollection 2019.
J Exp Med. 2005 Dec 19;202(12):1623-6. doi: 10.1084/jem.20051600.
4
Natural killer T cells: rapid responders controlling immunity and disease.自然杀伤T细胞:控制免疫和疾病的快速反应者。
Int J Biochem Cell Biol. 2005 Jul;37(7):1337-43. doi: 10.1016/j.biocel.2004.11.019. Epub 2005 Jan 8.
5
Human cytokine-induced killer cells have enhanced in vitro cytolytic activity via non-viral interleukin-2 gene transfer.通过非病毒白细胞介素-2基因转移,人细胞因子诱导的杀伤细胞在体外具有增强的细胞溶解活性。
Genet Vaccines Ther. 2004 Aug 25;2:12. doi: 10.1186/1479-0556-2-12. eCollection 2004.
6
NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo.在体内通过α-半乳糖神经酰胺激活自然杀伤细胞介导的细胞毒性过程中,自然杀伤T细胞作为调节细胞而非杀伤细胞发挥作用。
Immunol Lett. 2004 Aug 15;95(1):5-11. doi: 10.1016/j.imlet.2004.04.012.
7
Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide.通过靶向针对硫苷脂的独特、非恒定的CD1d反应性T细胞群体来预防自身免疫。
J Exp Med. 2004 Apr 5;199(7):947-57. doi: 10.1084/jem.20031389. Epub 2004 Mar 29.
8
Cytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemia.细胞因子诱导的杀伤细胞:对白血病具有溶细胞特异性的自然杀伤样T细胞。
Leuk Lymphoma. 2003 Sep;44(9):1457-62. doi: 10.3109/10428190309178764.
9
Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells.细胞因子诱导的杀伤细胞肿瘤细胞识别中涉及的效应细胞的表型特征及鉴定
Exp Hematol. 1993 Dec;21(13):1673-9.
10
A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.一种新的人类CD3+CD56+细胞群体,源自T细胞,对严重联合免疫缺陷小鼠具有强大的体内抗肿瘤活性。
J Immunol. 1994 Aug 15;153(4):1687-96.